These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 17169100

  • 21. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
    Nishijima S, Akamatsu H, Akamatsu M, Kurokawa I, Asada Y.
    J Dermatol; 1994 Mar; 21(3):166-71. PubMed ID: 8014270
    [Abstract] [Full Text] [Related]

  • 22. [The resistance of Propionibacterium acnes and Staphylococcus epidermidis to cyclines. The Research and Study Group on Acne].
    Noyon V, Legallou F, Richet H, Dreno B.
    Ann Dermatol Venereol; 1998 Dec; 125(12):885-7. PubMed ID: 9922860
    [Abstract] [Full Text] [Related]

  • 23. Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore.
    Tan HH, Goh CL, Yeo MG, Tan ML.
    Ann Acad Med Singap; 2001 Jan; 30(1):22-5. PubMed ID: 11242619
    [Abstract] [Full Text] [Related]

  • 24. [Bacterial resistance in acne? A meta-analysis of the controversy].
    Alvarez-Sánchez M, Rodríguez-Ayala E, Ponce-Olivera RM, Tirado-Sánchez A, Arellano-Mendoza MI.
    Cir Cir; 2016 Jan; 84(3):190-5. PubMed ID: 26738649
    [Abstract] [Full Text] [Related]

  • 25. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
    Ross JI, Snelling AM, Eady EA, Cove JH, Cunliffe WJ, Leyden JJ, Collignon P, Dréno B, Reynaud A, Fluhr J, Oshima S.
    Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569
    [Abstract] [Full Text] [Related]

  • 26. In vitro antimicrobial susceptibility patterns of Propionibacterium acnes isolated from patients with acne vulgaris.
    Biswal I, Gaind R, Kumar N, Mohanty S, Manchanda V, Khunger N, V R, Deb M.
    J Infect Dev Ctries; 2016 Oct 31; 10(10):1140-1145. PubMed ID: 27801379
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Tetracycline-resistant staphylococci in acne vulgaris.
    Shalita AR, Rosenthal SA.
    Acta Derm Venereol; 1972 Oct 31; 52(1):64-6. PubMed ID: 4111110
    [No Abstract] [Full Text] [Related]

  • 30. Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes biotypes 1-5.
    Akamatsu H, Nishijima S, Takahashi M, Ushijima T, Asada Y.
    J Dermatol; 1991 May 31; 18(5):247-51. PubMed ID: 1834712
    [Abstract] [Full Text] [Related]

  • 31. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
    Abeck D.
    MMW Fortschr Med; 2003 Dec 18; 145(51-52):29. PubMed ID: 14974325
    [No Abstract] [Full Text] [Related]

  • 32. Topical antibiotics and topical antimicrobial agents in acne therapy.
    Leyden JJ, McGinley K, Mills OH, Kligman AM.
    Acta Derm Venereol Suppl (Stockh); 1980 Dec 18; Suppl 89():75-82. PubMed ID: 6451130
    [No Abstract] [Full Text] [Related]

  • 33. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
    Alkhawaja E, Hammadi S, Abdelmalek M, Mahasneh N, Alkhawaja B, Abdelmalek SM.
    BMC Dermatol; 2020 Nov 17; 20(1):17. PubMed ID: 33203374
    [Abstract] [Full Text] [Related]

  • 34. In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico.
    González R, Welsh O, Ocampo J, Hinojosa-Robles RM, Vera-Cabrera L, Delaney ML, Gómez M.
    Int J Dermatol; 2010 Sep 17; 49(9):1003-7. PubMed ID: 20931669
    [Abstract] [Full Text] [Related]

  • 35. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S, Kurokawa I, Katoh N, Watanabe K.
    J Dermatol; 2000 May 17; 27(5):318-23. PubMed ID: 10875198
    [Abstract] [Full Text] [Related]

  • 36. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents.
    Nishijima S, Kurokawa I, Kawabata S.
    J Int Med Res; 1996 May 17; 24(6):473-7. PubMed ID: 8959531
    [Abstract] [Full Text] [Related]

  • 37. First report of high levels of clindamycin-resistant Propionibacterium acnes carrying erm(X) in Japanese patients with acne vulgaris.
    Nakase K, Nakaminami H, Noguchi N, Nishijima S, Sasatsu M.
    J Dermatol; 2012 Sep 17; 39(9):794-6. PubMed ID: 22142418
    [No Abstract] [Full Text] [Related]

  • 38. Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes.
    Aoki S, Nakase K, Hayashi N, Noguchi N.
    J Med Microbiol; 2019 Jan 17; 68(1):26-30. PubMed ID: 30431414
    [Abstract] [Full Text] [Related]

  • 39. [In vitro resistance of Propionibacterium acnes and Staphylococcus epidermidis to antibiotics: should our antibiotic prescription practices for the treatment of acne be changed?].
    Bourgault-Villada I.
    Ann Dermatol Venereol; 1998 Dec 17; 125(12):879-80. PubMed ID: 9922858
    [No Abstract] [Full Text] [Related]

  • 40. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance.
    Leyden JJ, Del Rosso JQ, Webster GF.
    Cutis; 2007 Jun 17; 79(6 Suppl):9-25. PubMed ID: 17649854
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.